Abstract
Historically, nature has provided the source for the majority of the drugs in use today. More than 20,000 microbial secondary metabolites have been described, but only a small percentage of these have been carried forward as natural product drugs. Natural products are in tough competition with large chemical libraries and with combinatorial chemistries. Hence, each step of a natural product program has to be more efficient than ever, starting from the collection of environmental samples and the selection of strains, to metabolic expression, genetic exploitation, sample preparation and chemical dereplication. This review will focus on approaches for diversifying microbial natural product strains and extract libraries, while decreasing genetic and chemical redundancy.
Similar content being viewed by others
References
Abbanat D, Maiese W, Greenstein M (1999) Biosynthesis of the pyrroindomycins by Streptomyces rugosporus LL-42D005; characterization of nutrient requirements. J Antibiot (Tokyo) 52:117–126
Abdel-Fattah YR, et al (2002) Numerical modeling of ferrous-ion oxidation rate in Acidithiobacillus ferrooxidans ATCC 23270: optimization of culture conditions through statistically designed experiments. Acta Microbiol Pol 51:225–235
Aharonowitz Y (1980) Nitrogen metabolite regulation of antibiotic biosynthesis. Annu Rev Microbiol 34:209–233
Ahmadjian V (1965) Lichens. Annu Rev Microbiol 19:1–20
Ananda K, Sridhar K (2002) Diversity of endophytic fungi in the roots of mangrove species on the west coast of India. Can J Microbiol 48:871–878
Askenazi M, et al (2003) Integrating transcriptional and metabolite profiles to direct the engineering of lovastatin-producing fungal strains. Nat Biotechnol 21:150–156
Auerbach D, et al (2002) The post-genomic era of interactive proteomics: facts and perspectives. Proteomics 2:611–623
Barberel S, Walker J (2000) The effect of aeration upon secondary metabolism of microorganisms. Biotechnol Genet Eng Rev 17:281–323
Bastert J, et al (1999) Identification of dermatophytes by Fourier transform infrared spectroscopy (FT-IR). Mycoses 42:525–528
Bentley S, Chater KF (2002) Complete genome sequence of the model actinomycetes Streptomyces coelicolor A(3)2. Nature 417:141–147
Betina V (1994) Bioactive secondary metabolites of microorganisms. Progress in Industrial Microbiology, vol 30
Bobzin SC, et al (2000a) Application of liquid chromatography-nuclear magnetic resonance spectroscopy to the identification of natural products. J Chromatogr B Biomed Sci Appl 748:259–267
Bobzin SC, et al (2000b) LC-NMR: a new tool to expedite the dereplication and identification of natural products. J Ind Microbiol Biotechnol 25:342–345
Bode HB, et al (2002) Big effects from small changes: possible ways to explore nature's chemical diversity. Chembiochem 3:619–627
Boeck L, et al (1971) Production of anticapsine by Streptomyces griseoplanus. Appl Microbiol Biotechnol 21:1075–1079
Bram RJ, et al (1993) Identification of the immunophilins capable of mediating inhibition of signal transduction by cyclosporin A and FK506: roles of calcineurin binding and cellular location. Mol Cell Biol 13:4760–4769
Brandao PF, et al (2002a) Discrimination and taxonomy of geographically diverse strains of nitrile-metabolizing actinomycetes using chemometric and molecular sequencing techniques. Environ Microbiol 4:262–276
Brandao PF, et al (2002b) Dereplication for biotechnology screening: PyMS analysis and PCR-RFLP-SSCP (PRS) profiling of 16S rRNA genes of marine and terrestrial actinomycetes. Appl Microbiol Biotechnol 58:77–83
Breinbauer R, et al. (2002) From protein domains to drug candidates—natural products as guiding principles in the design and synthesis of compound libraries. Angew Chem Int Ed Engl 41:2879–2890
Brewer DG, et al (1977) Beneficial effects of catalase or pyruvate in a most-probable-number technique for the detection of Staphylococcus aureus. Appl Environ Microbiol 34:797–800
Bruns A, et al (2002) Cyclic AMP and acyl homoserine lactones increase the cultivation efficiency of heterotrophic bacteria from the Central Baltic Sea. Appl Environ Microbiol 68:3978–3987
Bull AT (2000) Clean technology: industry and environment, a viable partnership? Biologist (London) 47:61–64
Bull AT, et al (2000) Search and discovery strategies for biotechnology: the paradigm shift. Microbiol Mol Biol Rev 64:573–606
Calvo AM, et al (2002) Relationship between secondary metabolism and fungal development. Microbiol Mol Biol Rev 66:447–459
Castillo UF, et al (2002) Munumbicins, wide-spectrum antibiotics produced by Streptomyces NRRL 30562, endophytic on Kennedia nigriscans. Microbiology 148:2675–2685
Che Y, et al (2002) Decipinin A and decipienolides A and B: new bioactive metabolites from the coprophilous fungus Podospora decipiens. J Nat Prod 65:916–919
Chen G, Wang YS, Li X, Waters B, Davies J (2000) Enhanced production of microbial metabolites in the presence of dimethyl sulfoxide. J Antibiot (Tokyo) 53:1145–1153
Christiansen G, et al (2003) Microcystin biosynthesis in planktothrix: genes, evolution, and manipulation. J Bacteriol 185:564–572
Cochran A (2000) Antagonists of protein-protein interactions. Chem Biol 7:R85–R94
Cohan FM (2001) Bacterial species and speciation. Syst Biol 50:513–524
Connon SA, Giovannoni SJ (2002) High-throughput methods for culturing microorganisms in very-low-nutrient media yield diverse new marine isolates. Appl Environ Microbiol 68:3878–3885
Courtois S, et al (2003) Recombinant environmental libraries provide access to microbial diversity for drug discovery from natural products. Appl Environ Microbiol 69:49–55
Crameri A, et al (1998) DNA shuffling of a family of genes from diverse species accelerates directed evolution. Nature 391:288–291
Cremin PA, Zeng L (2002) High-throughput analysis of natural product compound libraries by parallel LC-MS evaporative light scattering detection. Anal Chem 74:5492–5500
Czaran TL, et al (2002) Chemical warfare between microbes promotes biodiversity. Proc Natl Acad Sci USA 99:786–790
Davidson SK, et al (2001) Evidence for the biosynthesis of bryostatins by the bacterial symbiont "Candidatus Endobugula sertula" of the bryozoan Bugula neritina. Appl Environ Microbiol 67:4531–4537
Davies J (1999) Millennium bugs. Trends Biochem Sci 24:M2–M5
Degenkolb T, Heinze S, Schlegel B, Strobel G, Grafe U (2002) Formation of new lipoaminopeptides, acremostatins A, B, and C, by co-cultivation of Acremonium sp. Tbp-5 and Mycogene rosea DSM 12973. Biosci Biotechnol Biochem 66:883–886
Demain A (1998a) Induction of secondary metabolism. Int Microbiol 1:259–264
Demain A (1998b) Microbial natural products: alive and well in 1998. Nat Biotechnol 16:3–4
Demain A (1999) Pharmaceutically active secondary metabolites of microorganisms. Appl Microbiol Biotechnol 52:455–463
Dictionary of natural compounds (2002) Chapman and Hall chemical database. Chapman and Hall, London, www.chemnetbase.com
Doolittle W (1999) Phylogenic classification and the universal tree. Science 284:2124–2128
Eldridge G, et al (2002) High-throughput method for the production and analysis of large natural product libraries for drug discovery. Anal Chem 74:3963–3971
Feling RH, et al (2003) Salinosporamide A: a highly cytotoxic proteasome inhibitor from a novel microbial source, a marine bacterium of the new genus Salinospora. Angew Chem Int Ed Engl 42:355–357
Ferenci T (1996) Adaptation to life at micromolar nutrient levels: the regulation of Escherichia coli glucose transport by endoinduction and cAMP. FEMS Microbiol Rev 18:301–317
Fernandes P (2001) Molecular recognition: identifying compounds and their targets. J Cell Biochem 137:1–6
Firn RD, Jones CG (2000) The evolution of secondary metabolism—a unifying model. Mol Microbiol 37:989–994
Foissner W (1999) Notes on the soil ciliate biota (Protozoa, Ciliophora) from the Shimba Hills in Kenya (Africa): diversity and description of three new genera and ten new species. Biodiversity Conserv 8:319–389
Gerth K, Bedorf N, Hofle G, Irschik H, Reichenbach H (1996) Epothilons A and B: antifungal and cytotoxic compounds from Sorangium cellulosum (Myxobacteria). Production, physico-chemical and biological properties. J Antibiot (Tokyo) 49:560–563
Goodfellow M, et al (1997) Curie-point pyrolysis mass spectrometry as a tool in clinical microbiology. Zentralbl Bakteriol 285:133–156
Gotoh T, Nakahara K, Nishiura T, Hashimoto M, Kino T, Kuroda Y, Okuhara M, Kohsaka M, Aoki H, Imanaka H (1982) Studies on a new immunoactive peptide, FK-156. II Fermentation, extraction and chemical and biological characterization. J Antibiot (Tokyo) 35:1286–1292
Grabley S, Thiericke R (1999) The impact of natural products on drug discovery. In: Grabley S, Thiericke R (eds) Drug discovery from nature. Springer, New York Berlin Heidelberg, pp 3–37
Handelsman J, et al (1998) Molecular biological access to the chemistry of unknown soil microbes: a new frontier for natural products. Chem Biol 5:R245–R249
Harvey A (2000) Strategies for discovery drugs from previously unexplored natural products. Drug Discov Today 5:294–300
Henkel T, et al (1999) Statistical investigation into the structural complementarity of natural products and synthetic compounds. Angew Chem Int Ed Engl 38:643–647
Higgs RE, et al (2001) Rapid method to estimate the presence of secondary metabolites in microbial extracts. Appl Environ Microbiol 67:371–376
Hopwood D (1999) Forty years of genetics with Streptomyces: from in vivo through in vitro to silico. Microbiology 145:2183–2202
Hopwood DA, et al (1985) Production of 'hybrid' antibiotics by genetic engineering. Nature 314:642–644
Horinoushi S (2002) A microbial hormone, A-factor, as a master switch for morphological differentiation and secondary metabolism in Streptomyces griseus. Front Biosci 7:2045–2057
Hugenholtz P, et al (1998) Impact of culture-independent studies on the emerging phylogenetic view of bacterial diversity. J Bacteriol 180:4765–4774
Hung DT, et al (1996) Understanding and controlling the cell cycle with natural products. Chem Biol 3:623–639
Jensen PR, Fenical W (1994) Strategies for the discovery of secondary metabolites from marine bacteria: ecological perspectives. Annu Rev Microbiol 48:559–584
Kaeberlein T, et al (2002) Isolating "uncultivable" microorganisms in pure culture in a simulated natural environment. Science 296:1127–1129
Kalish H, et al (2001) Reactivity of mono-meso-substituted iron(II) octaethylporphyrin complexes with hydrogen peroxide in the absence of dioxygen. Evidence for nucleophilic attack on the heme. J Am Chem Soc 123:11719–11727
Kellenberger E (2001) Exploring the unknown: the silent revolution of microbiology. EMBO Rep 2:5–7
Kennedy J, Hutchinson CR (1999) Nurturing nature: engineering new antibiotics. Nat Biotechnol 17:538–539
Kupfer D, Reece CA, Clifton SW, Roe BA, Prade RA (1997) Multicellular ascomycetous fungal genomes contain more than 8000 genes. Fungal Genet Biol 21:364–372
Luchese R, Harrigan W (1993) Biosynthesis of aflatoxin—the role of nutritional factors. J Appl Bacteriol 74:5–14
McDaniel R, et al (1999) Multiple genetic modifications of the erythromycin polyketide synthase to produce a library of novel "unnatural" natural products. Proc Natl Acad Sci USA 96:1846–1851
Minas W, et al (2000) Streptomycetes in micro-cultures: growth, production of secondary metabolites, and storage and retrieval in the 96-well format. Antonie Van Leeuwenhoek 78:297–305
Mincer TJ, et al (2002) Widespread and persistent populations of a major new marine actinomycete taxon in ocean sediments. Appl Environ Microbiol 68:5005–5011
Monaghan RL, Polishook JD, Pecore VJ, Bills GF, Nallin M, Omstead SLS (1995) Discovery of novel secondary metabolites from fungi—is it really a random walk through a random forest? Can J Bot 73:S925–S931
Nielsen NP, et al (1999) Full second-order chromatographic/spectrometric data matrices for automated sample identification and component analysis by non-data-reducing image analysis. Anal Chem 71:727–735
Nisbet LJ, Moore M (1997) Will natural products remain an important source of drug research for the future? Curr Opin Biotechnol 8:708–712
Omura S, Ikeda H, Ishikawa J, Hanamoto A, Takahashi C, Shinose M, Takahashi Y, Horikawa H, Nakazawa H, Osonoe T, Kikuchi H, Shiba T, Sakaki Y, Hattori M (2001) Genome sequence of an industrial microorganism Streptomyces avermitilis deducing the ability of producing secondary metabolites. Proc Natl Acad Sci USA 98:12215–12220
Pfefferle C, Theobald U, Gurtler H, Fiedler H (2001) Improved secondary metabolite production in the genus Streptosporangium by optimization of the fermentation conditions. J Biotechnol 23:135–142
Pierceall W, et al (2003) Affinity capillary electrophoresis analyses of protein-protein interactions in target-directed drug discovery. In: Haian F (ed) Protein-protein interactions. Methods in molecular biology series, Humana, Totowa, N.J., (in press)
Pradella S, Hans A, Spoer C, Reichenbach H, Gerth K, Beyer S (2002) Characterisation, genome size and genetic manipulation of the myxobacterium Sorangium cellulosim So ce56. Arch Microbiol 178:484–492
Proksch PR, et al (2002) Drugs from the sea-current status and microbiological implications. Appl Microbiol Biotechnol 59:125–134
Reichenbach H (2001) Myxobacteria, producers of novel bioactive substances. J Ind Microbiol Biotechnol 27:149–156
Rikkinen J, et al (2002) Lichen guilds share related cyanobacterial symbionts. Science 297:357
Rix U, et al (2002) Modification of post-PKS tailoring steps through combinatorial biosynthesis. Nat Prod Rep 19:542–580
Robinson T, Singh D, Nigam P (2001) Solid-state fermentation: a promising microbial technology for secondary metabolite production. Appl Microbiol Biotechnol 55:284–289
Rondon MR, et al (2000) Cloning the soil metagenome: a strategy for accessing the genetic and functional diversity of uncultured microorganisms. Appl Environ Microbiol 66:2541–2547
Saitoh K, et al (1993) Pramicidin S, a new pramicidin analog. I Taxonomy, fermentation and biological activities. J Antibiot (Tokyo) 46:580–588
Sandor E, Szentirmai A, Paul GC, Thomas CR, Pocsi L, Karaffa L (2001) Analysis of the relationship between growth, cephalosporin C production, and fragmentation in Acremonium chrysogenum. Can J Microbiol 47:801–806
Schiewe HJ, Zeeck A (1999) Cineromycins, gamma-butyrolactones and ansamycins by analysis of the secondary metabolite pattern created by a single strain of Streptomyces. J Antibiot (Tokyo) 52:635–642
Schimana J, Gebhardt K, Holtzel A, Schmid DG, Sussmuth R, Muller J, Pukall R, Fiedler HP (2002) Arymomycins A and B, new biaryl-bridged lipopeptide antibiotics produced by Streptomyces sp. Tu6075. I Taxonomy, fermentation, isolation and biological activities. J Antibiot (Tokyo) 55:565–570
Schloter M, et al (2000) Ecology and evolution of bacterial microdiversity. FEMS Microbiol Rev 24:647–660
Schultz M, Tsaklakidis C (1997) Nachr Chem Tech 45:159
Seow K, et al (1997) A study of iterative type II polyketide synthases, using bacterial genes cloned from soil DNA: a means to access and use genes from uncultured microorganisms. J Bacteriol 179:7360–7368
Shimada N, Hasegawa S, Harada T, Tomisawa T, Fuji A, Takita T (1986) Oxetanocin, a novel nucleoside from bacteria. J Antibiot (Tokyo) 39:1623–1625
Shrestha K, et al (2001) Evidence for paclitaxel from three new endophytic fungi of Himalayan yew of Nepal. Planta Med 67:374–376
Silakowski B, Kunze B, Muller R (2001) Multiple hybrid polyketide synthase/non-ribosomal peptide synthetase gene clusters in the myxobacterium Stigmatella aurantiaca. Gene 275:233–240
Smedsgaard J (1997) Micro-scale extraction procedure for standardized screening of fungal metabolite production in cultures. J Chromatogr A. 760:264–270
Staley J, Gosink J (1999) Poles apart: biodiversity and biogeography of sea ice bacteria. Annu Rev Microbiol 53:189–215
Stokes HW, et al (2001) Gene cassette PCR: sequence-independent recovery of entire genes from environmental DNA. Appl Environ Microbiol 67:5240–5246
Strobel G (2002) Rainforest endophytes and bioactive products. Crit Rev Biotechnol 22:315–333
Tan R, Zou W (2001) Endophytes: a rich source of functional metabolites. Nat Prod Rep 18:449–459
Trujillo M, Gremlich HU, Sanglier JJ (1997) Selection strategy of traditional microorganisms for pharmacological screenings. Developments in Industrial Microbiology, vol 33
Tulp M, Bohlin L (2002) Functional versus chemical diversity: is biodiversity important for drug discovery? Trends Pharmacol Sci 23:225–231
Urizar NL, et al (2002) A natural product that lowers cholesterol as an antagonist ligand for FXR. Science 296:1703–1706
VanMiddlesworth F, Cannell RJP (1998) Dereplication and partial identification of natural products. In: Cannell RJP (ed) Methods in biotechnology, vol 4: natural product isolation. Humana, Totowa, N.J., pp 279–327
Verdine G (1996) The combinatorial chemistry of nature. Nature 384 [Suppl]:11–13
Vermis K, et al (2002) Evaluation of restriction fragment length polymorphism analysis of 16S rDNA as a tool for genomovar characterisation within the Burkholderia cepacia complex. FEMS Microbiol Lett 214:1–5
Walsh CT (2002) Combinatorial biosynthesis of antibiotics: challenges and opportunities. Chembiochem 3:125–134
Wei ZM, et al (1992) Harpin, elicitor of the hypersensitive response produced by the plant pathogen Erwinia amylovora. Science 257:85–88
Weinberg E (1978) Secondary metabolism: regulation by phosphate and trace elements. Folia Microbiol 23:496–504
Whitman WB, et al (1998) Prokaryotes: the unseen majority. Proc Natl Acad Sci USA 95:6578–6583
Wieling J, et al (1993) Chemometrics in bioanalytical sample preparation. A fractionated combined mixture and factorial design for the modelling of the recovery of five tricyclic amines from plasma after liquid-liquid extraction prior to high-performance liquid chromatography. J Chromatogr 629:181–199
Wintzingerode F von, et al (2002) Base-specific fragmentation of amplified 16S rRNA genes analyzed by mass spectrometry: a tool for rapid bacterial identification. Proc Natl Acad Sci USA 99:7039–7044
Xue Q, et al (1999) A multiplasmid approach to preparing large libraries of polyketides. Proc Natl Acad Sci USA 96:11740–11745
Yurek DA, et al (2002) Development of a system to evaluate compound identity, purity, and concentration in a single experiment and its application in quality assessment of combinatorial libraries and screening hits. J Comb Chem 4:138–148
Zahn JA, et al (2001) Use of direct-infusion electrospray mass spectrometry to guide empirical development of improved conditions for expression of secondary metabolites from actinomycetes. Appl Environ Microbiol 67:377–386
Zazopoulos E, et al (2003) A genomics-guided approach for discovering and expressing cryptic metabolic pathways. Nat Biotechnol 21:187–190
Zengler K, et al (2002) Cultivating the uncultured. Proc Natl Acad Sci USA 99:15681–15686
Zhang YX, et al (2002) Genome shuffling leads to rapid phenotypic improvement in bacteria. Nature 415:644–646
Zinniel D, et al (2002) Isolation and characterization of endophytic colonizing bacteria from agronomic crops and prairie plants. Appl Environ Microbiol 68:2198–2208
Acknowledgements
The authors would like to thank Drs. Andy Staley, Xiaoyu Shen, Eugenie Boutin, Hyedong Yoo, Alexei Belenky, Bill Pierceall, Baoliang Cui and Shuhui Chen for critical reading and comments on the manuscript. Additional gratitude is extended to the drug discovery teams at Cetek, Inc.
Author information
Authors and Affiliations
Corresponding author
Additional information
V. Knight and J.-J. Sanglier contributed equally to this work
Rights and permissions
About this article
Cite this article
Knight, V., Sanglier, JJ., DiTullio, D. et al. Diversifying microbial natural products for drug discovery. Appl Microbiol Biotechnol 62, 446–458 (2003). https://doi.org/10.1007/s00253-003-1381-9
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00253-003-1381-9